Treatment of gliomas in adults.
Gliomas are the most common tumors in the brain and are almost always malignant in adults. The most malignant and most common glioma is glioblastoma multiforme. Median survival of patients with glioblastoma is less than 20 months following treatment. This poor prognosis reflects the limited efficacy of the currently available treatment modalities. Therefore, many attempts have been made to improve the treatment of this lethal disease. This paper reviews the progress that has been made recently in the treatment of malignant glioma with a focus on studies reported during the last year.
Ushio
Y
Y
Department of Neurosurgery, Kumamoto University Medical School, Japan.
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001918:Brachytherapy; D001932:Brain Neoplasms / Q000628:therapy*; D003131:Combined Modality Therapy; D005910:Glioma / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy
D000911:Antibodies, Monoclonal